Company Valuation: Shockwave Medical

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2025 2026
Market Cap 1 1,350 3,553 6,296 7,431 7,031 12,568 12,568
Change - 163.22% 77.18% 18.03% -5.39% - 0%
Enterprise Value (EV) 1,168 3,368 6,112 7,151 6,772 12,568 12,568
Change - 188.21% 81.49% 17% -5.29% - 0%
P/E -20.5x -52.1x -686x 36.1x 49.5x - -
PBR 7.17x 15.9x 25.9x 14.6x 10.5x - -
PEG - 7.43x 7.9x -0x -1.5x - -
Capitalization / Revenue 31,448,707x 52,418,900x 26,548,396x 15,174,017x 9,628,534x - -
EV / Revenue - - - - - - -
EV / EBITDA - - - - - - -
EV / EBIT - - - - - - -
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -2.14 -1.99 -0.26 5.7 3.85 - -
Distribution rate - - - - - - -
Net sales 42.93 67.79 237.1 489.7 730.2 - -
EBITDA -46.86 -53.45 29.96 173.9 242.7 - -
EBIT -51.84 -65.66 -0.871 124.1 159.1 - -
Net income -51.11 -65.7 -9.136 216 147.3 - -
Net Debt -181.5 -185.7 -183.9 -280.3 -258.7 - -
Reference price 2 43.92 103.72 178.33 205.61 190.56 334.75 334.75
Nbr of stocks (in thousands) 30,738 34,260 35,304 36,142 36,897 37,544 37,544
Announcement Date 2/13/20 2/17/21 2/17/22 2/16/23 2/15/24 - -
1USD in Million2
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 12.57B
72.42x7.62x44.42x-.--% 12.58B
21.12x2.13x10.47x2.11% 6.76B
35.18x1.65x10.3x-.--% 5.78B
27.61x5.69x15.41x1.38% 5.49B
33.55x9.92x25.07x0.6% 5.09B
18.08x3.02x15.7x3.45% 3.97B
-13.33x2.53x-23.03x - 1.89B
-17.22x416.18x-74.06x-.--% 1.67B
18.55x2.27x8.92x2.05% 1.56B
Average 21.77x 50.11x 3.69x 1.2% 5.74B
Weighted average by Cap. 36.31x 20.49x 18.09x 0.97%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. SWAV Stock
  4. Valuation Shockwave Medical